Skip to main content
Premium Trial:

Request an Annual Quote

Premaitha Health Receives Accreditation from English Regulator for NIPT Lab

NEW YORK (GenomeWeb) – Premaitha Health has received accreditation for its new noninvasive prenatal testing laboratory in Manchester from the Care Quality Commission, a regulator of health and care services in England.

Premaitha's clinical laboratory, based in the Manchester Science Park, will provide testing services on an interim basis for customers who are in the process of establishing the company's Iona test in their own laboratory. In addition, the lab will provide back-up services for customers during busy periods.

"We want to be able to offer a clinical laboratory service to support customers keen to provide the Iona test at the earliest possible opportunity," said Premaitha CEO Stephen Little in a statement. "The accreditation validates the quality of our facilities and the expertise of our clinical scientists."

Premaitha has licensed the CE-marked Iona test to a number of clinical laboratories in the UK and elsewhere in Europe.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.